Microneedling radiofrequency followed by topical exosome application therapy for pattern hair loss: A scoping review

Ioannis-Alexios Koumprentziotis1, Eleni Kroumpouzos2, Shohreh Delavar3

  • 1First Department of Dermatology and Venereology, Medical School, "Andreas Sygros" Hospital for Skin Diseases, National and Kapodistrian University of Athens, Athens, Greece.

PubMed

Insights

Microneedling radiofrequency (MNRF) combined with exosome therapy shows promise for pattern hair loss (PHL). This treatment significantly increased hair density and diameter, with high patient satisfaction and no reported adverse events.

Area of Science:

  • Dermatology and Regenerative Medicine
  • Hair Follicle Biology
  • Aesthetic Medicine

Background:

  • Pattern hair loss (PHL), or androgenetic alopecia, is a common condition with limited FDA-approved treatments (minoxidil, finasteride) that have potential side effects.
  • Emerging therapies like microneedling radiofrequency (MNRF) and exosome therapy offer novel approaches for hair regrowth.
  • Exosomes promote hair follicle regeneration via signaling pathways, while MNRF stimulates regrowth through controlled thermal injury.

Purpose of the Study:

  • To conduct a scoping review of MNRF and exosome therapies for PHL.
  • To prospectively evaluate the efficacy and safety of MNRF followed by topical exosome application in patients with PHL.

Main Methods:

  • A literature search was performed on PubMed, Google Scholar, and Cochrane databases for MNRF and exosome treatments for PHL.
  • Twenty patients with PHL (16 male, 4 female) received MNRF followed by topical exosome application.
  • Clinical evaluations included macroscopic photographs and digital image analysis using a trichoscopy device at baseline and 3, 6, and 9 months post-treatment.

Main Results:

  • Scoping review identified studies showing positive effects of MNRF and exosome therapy on hair regrowth.
  • MNRF followed by topical exosome application resulted in significant increases in mean hair density and diameter.
  • High patient satisfaction was reported, with no adverse events observed; treatment response was independent of sex or PHL severity.

Conclusions:

  • The combination of MNRF and topical exosome application demonstrates therapeutic potential for pattern hair loss.
  • This combined therapy appears safe and effective, improving hair density and diameter with high patient satisfaction.
  • Further randomized controlled trials are necessary to confirm efficacy and establish optimal treatment parameters.